N. Brack

Safety and Cost Effectiveness of a 10 × 109/L Trigger for Prophylactic Platelet Transfusions Compared With the Traditional 20 × 109/L Trigger: A Prospective Comparative Trial in 105 Patients With Acute Myeloid Leukemia

Hannes Wandt, Markus H. Frank, Gerhard Ehninger et al. · Blood · 1998 · 300 citations · Full text

Medicine, Hematology, Pharmacoeconomics +16

Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: Updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy

M. Engelhard, P. Meusers, G. Brittinger et al. · Annals of Oncology · 1991 · 46 citations · Full text

Medicine, Oncology, Medical Oncology +7

Recombinant human interferon-alpha in the treatment of angioimmunoblastic lymphadenopathy: results in 12 patients.

W. Siegert, C. Nerl, I. Meuthen et al. · PubMed · 1991 · 39 citations

Life Sciences, Immunology, Pharmacotherapy +6

Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML)

Arnold Ganser, Gerhard Heil, G. Seipelt et al. · Annals of Hematology · 2000 · 25 citations

Medicine, Hematology, Oncology +16